QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
NASDAQ:HQY

HealthEquity (HQY) Stock Price, News & Analysis

$78.07
+0.68 (+0.88%)
(As of 02/8/2024 ET)
Today's Range
$77.45
$78.82
50-Day Range
$62.44
$78.07
52-Week Range
$48.86
$78.84
Volume
443,466 shs
Average Volume
674,139 shs
Market Capitalization
$6.70 billion
P/E Ratio
229.62
Dividend Yield
N/A
Price Target
$83.25

HealthEquity MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
6.6% Upside
$83.25 Price Target
Short Interest
Healthy
3.37% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.81mentions of HealthEquity in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$3.18 M Sold Last Quarter
Proj. Earnings Growth
40.54%
From $1.48 to $2.08 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.39 out of 5 stars

Medical Sector

299th out of 911 stocks

Business Services, Not Elsewhere Classified Industry

41st out of 85 stocks


HQY stock logo

About HealthEquity Stock (NASDAQ:HQY)

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.

HQY Stock Price History

HQY Stock News Headlines

LIVE DEMO: Elon Musk’s AI hits 65 MPH
I just taped a live demonstration of Elon Musk’s AI in action. Elon already created an “army of millionaires” with Tesla. Looks like he’ll do it again with his AI because unlike ChatGPT, Elon’s AI works in the REAL world.
Comparing HealthEquity (NASDAQ:HQY) & Top KingWin (NASDAQ:TCJH)
ELV or HQY: Which Is the Better Value Stock Right Now?
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
HealthEquity (HQY) Performed Strongly in Q3
See More Headlines
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/05/2023
Today
2/08/2024
Next Earnings (Estimated)
3/19/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:HQY
Employees
3,208
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$83.25
High Stock Price Target
$95.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+6.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-26,140,000.00
Pretax Margin
4.67%

Debt

Sales & Book Value

Annual Sales
$861.75 million
Cash Flow
$2.75 per share
Book Value
$22.40 per share

Miscellaneous

Free Float
83,484,000
Market Cap
$6.70 billion
Optionable
Optionable
Beta
0.55
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report














HQY Stock Analysis - Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HQY shares.
View HQY analyst ratings
or view top-rated stocks.

What is HealthEquity's stock price target for 2024?

8 equities research analysts have issued 12-month price targets for HealthEquity's stock. Their HQY share price targets range from $72.00 to $95.00. On average, they expect the company's stock price to reach $83.25 in the next year. This suggests a possible upside of 6.6% from the stock's current price.
View analysts price targets for HQY
or view top-rated stocks among Wall Street analysts.

How have HQY shares performed in 2024?

HealthEquity's stock was trading at $66.30 at the start of the year. Since then, HQY shares have increased by 17.8% and is now trading at $78.07.
View the best growth stocks for 2024 here
.

Are investors shorting HealthEquity?

HealthEquity saw a decrease in short interest during the month of January. As of January 15th, there was short interest totaling 2,890,000 shares, a decrease of 8.3% from the December 31st total of 3,150,000 shares. Based on an average trading volume of 778,400 shares, the short-interest ratio is currently 3.7 days.
View HealthEquity's Short Interest
.

When is HealthEquity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024.
View our HQY earnings forecast
.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) posted its quarterly earnings results on Tuesday, December, 5th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.08. The business earned $249.22 million during the quarter, compared to the consensus estimate of $243.63 million. HealthEquity had a trailing twelve-month return on equity of 5.89% and a net margin of 3.00%.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity updated its FY 2025 earnings guidance on Monday, December, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion.

What is Jon Kessler's approval rating as HealthEquity's CEO?

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Mackenzie Financial Corp (2.11%), Dimensional Fund Advisors LP (1.64%), Allspring Global Investments Holdings LLC (1.41%), Charles Schwab Investment Management Inc. (1.17%), Geneva Capital Management LLC (1.01%) and DAVENPORT & Co LLC (0.59%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten.
View institutional ownership trends
.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HQY) was last updated on 2/8/2024 by MarketBeat.com Staff

My Account -